On Wednesday, 25 March 2026, Ocular Therapeutix (NASDAQ:OCUL) presented at the RBC Capital Markets Virtual Ophthalmology Conference. The company highlighted the promising results of its lead program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results